Clinical Trial Update: Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype [NA]

View source ↗

Summary

Completed clinical trial evaluating resiliency training delivered via Skype videoconferencing for patients with Neurofibromatosis types 1, 2, and Schwannomatosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type
• Neurofibromatosis Type 2
• Schwannomatosis

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Neurofibromatosis, Neurofibromatosis I | NA | Status: COMPLETED